{"id":32688,"date":"2026-05-11T11:23:41","date_gmt":"2026-05-11T11:23:41","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=32688"},"modified":"2026-05-11T11:23:41","modified_gmt":"2026-05-11T11:23:41","slug":"coretissue-launches-acl-clinical-cohort-study","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/","title":{"rendered":"\u30b3\u30a2\u30c6\u30a3\u30c3\u30b7\u30e5\u304cACL\u81e8\u5e8a\u30b3\u30db\u30fc\u30c8\u7814\u7a76\u3092\u958b\u59cb"},"content":{"rendered":"

\u30b3\u30a2\u30c6\u30a3\u30c3\u30b7\u30e5\u30fb\u30d0\u30a4\u30aa\u30a8\u30f3\u30b8\u30cb\u30a2\u30ea\u30f3\u30b0<\/a> Inc. (\u201cCTBE\u201d), a medical device start-up announces that the safety evaluation in the safety cohort of its clinical trial for anterior cruciate ligament (ACL) reconstruction with the medical device “Tissue Regenerative Ligament” (development code: CT-ACL001) sponsored by the company has been completed, and the randomized controlled cohort to verify safety and efficacy has been initiated. This randomized controlled cohort will use the standard treatment of ACL reconstruction using the patient’s own hamstring tendon as the control group and will be conducted at six facilities nationwide: Tokyo Women’s Medical University Hospital (where Professor Dr. Ken Okazaki, the clinical trial coordinator, is affiliated), Hirosaki University Hospital, Hiroshima University Hospital, Hokkaido University Hospital, Juntendo University Hospital, and Kobe University Hospital (listed in alphabetical order).<\/p>\n

Furthermore, the initial results of the safety evaluation cohort will be presented by Lecturer Dr. Masafumi Ito of the Department of Orthopedic Surgery, Tokyo Women’s Medical University at the 22nd Congress of the European Society of Sports Traumatology, Knee Surgery and Arthroscopy (ESSKA), held from May 20th of this year.<\/p>\n

\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a \u30aa\u30ea\u30f3\u30d1\u30b9\u3001EndoRobotics\u793e\u3068\u63d0\u643a\u3057\u3001\u5916\u79d1\u7528\u5185\u8996\u93e1\u691c\u67fb\u3092\u5f37\u5316<\/a><\/h4>\n

\u7121\u4f5c\u70ba\u5316\u30b3\u30db\u30fc\u30c8\u306e\u6982\u8981\uff08\u8a73\u7d30\u306f\u81e8\u5e8a\u8a66\u9a13\u516c\u958b\u60c5\u5831\u3092\u3054\u53c2\u7167\u304f\u3060\u3055\u3044\uff09<\/p>\n

\u6cbb\u9a13\u7528\u6a5f\u5668\u7d44\u7e54\u518d\u751f\u976d\u5e2f\uff08\u958b\u767a\u30b3\u30fc\u30c9\uff1aCT-ACL001\uff09
\n\u5bfe\u8c61\u75be\u60a3\u524d\u5341\u5b57\u976d\u5e2f\u640d\u50b7\uff08\u518d\u5efa\u304c\u5fc5\u8981\uff09
\n\u76ee\u6a19\u75c7\u4f8b\u6570CT-ACL001\u518d\u5efa\u7fa438\u4f8b\u3001\u81ea\u5bb6\u8171\u518d\u5efa\u7fa419\u4f8b
\n\u5b9f\u65bd\u4e88\u5b9a\u6642\u671f2026\u5e745\u6708\u958b\u59cb
\n\u4eca\u5f8c\u306e\u4e88\u5b9a\u672c\u8a66\u9a13\u306e\u4e3b\u8981\u8a55\u4fa1\u9805\u76ee\u7d42\u4e86\u5f8c\u3001\u65e5\u672c\u306b\u304a\u3051\u308b\u533b\u7642\u6a5f\u5668\u306e\u88fd\u9020\u8ca9\u58f2\u627f\u8a8d\u7533\u8acb\u3092\u884c\u3046\u4e88\u5b9a\u3067\u3059\u3002.<\/p>\n

\u672c\u81e8\u5e8a\u8a66\u9a13\u3092\u542b\u3080\u7814\u7a76\u958b\u767a\u306f\u3001\u65e5\u672c\u533b\u7642\u7814\u7a76\u958b\u767a\u6a5f\u69cb\uff08AMED\uff09\u306e\u52a9\u6210\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002.<\/p>\n

\u30bd\u30fc\u30b9 \u30d3\u30b8\u30cd\u30b9\u30ef\u30a4\u30e4\u30fc<\/a><\/strong><\/p>","protected":false},"excerpt":{"rendered":"

CoreTissue BioEngineering Inc. (\u201cCTBE\u201d), a medical device start-up announces that the safety evaluation in the safety cohort of its clinical trial for anterior cruciate ligament (ACL) reconstruction with the medical device “Tissue Regenerative Ligament” (development code: CT-ACL001) sponsored by the company has been completed, and the randomized controlled cohort to verify safety and efficacy has been initiated. This randomized controlled cohort will use the standard treatment of ACL reconstruction using the patient’s own hamstring tendon as the control group and will be conducted at six facilities nationwide: Tokyo Women’s Medical University Hospital (where Professor Dr. Ken Okazaki, the clinical trial coordinator, is affiliated), Hirosaki University Hospital, Hiroshima University Hospital, Hokkaido […]<\/p>\n","protected":false},"author":4,"featured_media":32689,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,181,89,211,237,206],"tags":[150,6546,12897,12895,12896],"ppma_author":[205],"class_list":{"0":"post-32688","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-apac","8":"category-biotech","9":"category-health-tech","10":"category-japan","11":"category-news","12":"category-regional","13":"tag-biotech","14":"tag-clinical-trial","15":"tag-coretissue-bioengineering","16":"tag-health-technology","17":"tag-medical-devices"},"yoast_head":"\nCoreTissue Starts Randomized ACL Trial<\/title>\n<meta name=\"description\" content=\"CoreTissue BioEngineering has launched a randomized controlled cohort study for its ACL reconstruction treatment clinical trial in Japan.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CoreTissue Starts Randomized ACL Trial\" \/>\n<meta property=\"og:description\" content=\"CoreTissue BioEngineering has launched a randomized controlled cohort study for its ACL reconstruction treatment clinical trial in Japan.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-11T11:23:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/05\/Japanese-Medtech-Startup_-CoreTissue-BioEngineering_-Initiates-Randomized-Controlled-Cohort-in-the-Clinical-Trial-for-Anterior-Cruciate-Ligament-ACL-Reconstruction-Treatment.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NewsDesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"NewsDesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CoreTissue Starts Randomized ACL Trial","description":"CoreTissue BioEngineering has launched a randomized controlled cohort study for its ACL reconstruction treatment clinical trial in Japan.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/","og_locale":"ja_JP","og_type":"article","og_title":"CoreTissue Starts Randomized ACL Trial","og_description":"CoreTissue BioEngineering has launched a randomized controlled cohort study for its ACL reconstruction treatment clinical trial in Japan.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/","og_site_name":"itbusinesstoday","article_published_time":"2026-05-11T11:23:41+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/05\/Japanese-Medtech-Startup_-CoreTissue-BioEngineering_-Initiates-Randomized-Controlled-Cohort-in-the-Clinical-Trial-for-Anterior-Cruciate-Ligament-ACL-Reconstruction-Treatment.webp","type":"image\/webp"}],"author":"NewsDesk","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"NewsDesk","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/"},"author":{"name":"NewsDesk","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812"},"headline":"CoreTissue Launches ACL Clinical Cohort Study","datePublished":"2026-05-11T11:23:41+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/"},"wordCount":295,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/05\/Japanese-Medtech-Startup_-CoreTissue-BioEngineering_-Initiates-Randomized-Controlled-Cohort-in-the-Clinical-Trial-for-Anterior-Cruciate-Ligament-ACL-Reconstruction-Treatment.webp","keywords":["Biotech","clinical trial","CoreTissue BioEngineering","Health Technology","Medical Devices"],"articleSection":["APAC","Biotech","Health Tech","Japan","News","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/","name":"CoreTissue Starts Randomized ACL Trial","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/05\/Japanese-Medtech-Startup_-CoreTissue-BioEngineering_-Initiates-Randomized-Controlled-Cohort-in-the-Clinical-Trial-for-Anterior-Cruciate-Ligament-ACL-Reconstruction-Treatment.webp","datePublished":"2026-05-11T11:23:41+00:00","description":"CoreTissue BioEngineering has launched a randomized controlled cohort study for its ACL reconstruction treatment clinical trial in Japan.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/05\/Japanese-Medtech-Startup_-CoreTissue-BioEngineering_-Initiates-Randomized-Controlled-Cohort-in-the-Clinical-Trial-for-Anterior-Cruciate-Ligament-ACL-Reconstruction-Treatment.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/05\/Japanese-Medtech-Startup_-CoreTissue-BioEngineering_-Initiates-Randomized-Controlled-Cohort-in-the-Clinical-Trial-for-Anterior-Cruciate-Ligament-ACL-Reconstruction-Treatment.webp","width":1200,"height":800,"caption":"CoreTissue BioEngineering"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"CoreTissue Launches ACL Clinical Cohort Study"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812","name":"\u30cb\u30e5\u30fc\u30b9\u30c7\u30b9\u30af","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png74f313ad3d6fa27a1eee85c30be63d03","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","caption":"NewsDesk"},"sameAs":["https:\/\/itbusinesstoday.com"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/newsdesk\/"}]}},"authors":[{"term_id":205,"user_id":4,"is_guest":0,"slug":"newsdesk","display_name":"NewsDesk","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/32688","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=32688"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/32688\/revisions"}],"predecessor-version":[{"id":32690,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/32688\/revisions\/32690"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/32689"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=32688"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=32688"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=32688"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=32688"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}